Business Description
Avid Bioservices Inc
NAICS : 325412
SIC : 2834
ISIN : US05368M2052
Share Class Description:
CDMOP.PFD: 10 1/2 % Conv Pfd Shs Series -ETotal Employee Number:
371Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.14 | |||||
Debt-to-Equity | 4.59 | |||||
Debt-to-EBITDA | -14.33 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.58 | |||||
Beneish M-Score | -4.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.1 | |||||
3-Year Book Growth Rate | -9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.93 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | -5.11 | |||||
12-1 Month Momentum % | 9.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 84.51 | |||||
Days Sales Outstanding | 42.67 | |||||
Days Payable | 48.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 10.47 | |||||
Forward Dividend Yield % | 10.47 | |||||
5-Year Yield-on-Cost % | 10.47 | |||||
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -1.83 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 7.68 | |||||
Operating Margin % | -13.55 | |||||
Net Margin % | -101.07 | |||||
EBITDA Margin % | -9.53 | |||||
ROE % | -143.94 | |||||
ROA % | -39.92 | |||||
ROIC % | -5.61 | |||||
3-Year ROIIC % | -18.96 | |||||
ROC (Joel Greenblatt) % | -11.81 | |||||
ROCE % | -9.65 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.28 | |||||
PB Ratio | 17.82 | |||||
Price-to-Operating-Cash-Flow | 150.48 | |||||
EV-to-EBIT | -36.21 | |||||
EV-to-EBITDA | -67.71 | |||||
EV-to-Revenue | 6.45 | |||||
EV-to-FCF | -100.3 | |||||
Earnings Yield (Greenblatt) % | -2.76 | |||||
FCF Yield % | -1.21 |
GF Valueâ„¢
Avid Bioservices Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avid Bioservices Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2025-12-10 | -- | ||
| General meeting for 2025 | 2025-10-16 10:00 | -- | ||
| First quarter earnings conference call for 2026 | 2025-09-09 16:30 | -- | ||
| First quarter earnings results for 2026 | 2025-09-09 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2025-07-02 16:30 | -- | ||
| Annual report for 2025 | 2025-07-02 | -- | ||
| Fourth quarter earnings results for 2025 | 2025-07-02 | -- | ||
| Third quarter earnings conference call for 2025 | 2025-04-29 16:30 | -- | ||
| Third quarter earnings results for 2025 | 2025-04-24 | -- | ||
| Second quarter earnings conference call for 2025 | 2024-12-17 | -- |
Show
Entries
Guru Commentaries on NAS:CDMOP.PFD
No articles.
Press Release
Articles on Avid Bioservices Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers